Collegium Pharmaceutical, Inc. (COLL)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Dec 27, 2024

$29.11

P/E Ratio

12.56

Market Cap

$938.8M

Loading...
Description

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

Metrics

Overview

  • HQStoughton, MA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerCOLL
  • Price$29.11-1.29%

Trading Information

  • Market cap$938.80M
  • Float96.51%
  • Average Daily Volume (1m)476,858
  • Average Daily Volume (3m)441,771
  • EPS$2.74

Company

  • Revenue$599.25M
  • Rev growth (1yr)16.53%
  • Net income$9.33M
  • Gross margin60.76%
  • EBITDA margin60.56%
  • EBITDA$96.47M
  • EV$2.40B
  • EV/Revenue4.01
  • P/E12.56
  • P/S1.95
  • P/B4.00
Documents